FI944984A - Yhdisteet ja menetelmä IL-6 in vivo tapahtuvan valmistuksen säätämiseksi - Google Patents

Yhdisteet ja menetelmä IL-6 in vivo tapahtuvan valmistuksen säätämiseksi Download PDF

Info

Publication number
FI944984A
FI944984A FI944984A FI944984A FI944984A FI 944984 A FI944984 A FI 944984A FI 944984 A FI944984 A FI 944984A FI 944984 A FI944984 A FI 944984A FI 944984 A FI944984 A FI 944984A
Authority
FI
Finland
Prior art keywords
compounds
controlling
vivo production
vivo
production
Prior art date
Application number
FI944984A
Other languages
English (en)
Swedish (sv)
Other versions
FI944984A0 (fi
Inventor
Raymond A Daynes
Barbara A Araneo
Original Assignee
Univ Utah
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Utah filed Critical Univ Utah
Publication of FI944984A0 publication Critical patent/FI944984A0/fi
Publication of FI944984A publication Critical patent/FI944984A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI944984A 1992-05-01 1994-10-24 Yhdisteet ja menetelmä IL-6 in vivo tapahtuvan valmistuksen säätämiseksi FI944984A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US87761292A 1992-05-01 1992-05-01
PCT/US1993/004067 WO1993021771A1 (en) 1992-05-01 1993-04-30 Compositions and methods for regulating il-6 production in vivo

Publications (2)

Publication Number Publication Date
FI944984A0 FI944984A0 (fi) 1994-10-24
FI944984A true FI944984A (fi) 1994-11-16

Family

ID=25370328

Family Applications (1)

Application Number Title Priority Date Filing Date
FI944984A FI944984A (fi) 1992-05-01 1994-10-24 Yhdisteet ja menetelmä IL-6 in vivo tapahtuvan valmistuksen säätämiseksi

Country Status (7)

Country Link
EP (1) EP0637915A4 (fi)
JP (1) JPH07506372A (fi)
AU (1) AU675222B2 (fi)
CA (1) CA2134228A1 (fi)
FI (1) FI944984A (fi)
NZ (1) NZ252491A (fi)
WO (1) WO1993021771A1 (fi)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5922701A (en) * 1992-05-01 1999-07-13 University Of Utah Research Foundation Method for enhancing or accelerating re-epithelialization or re-endothelialization of a tissue
US5407927A (en) * 1993-04-16 1995-04-18 The Regents Of The University Of California Treatment of mild depression and restoration of IGF-I levels in aging by dehydroepiandrosterone
WO1996003993A2 (en) * 1994-08-05 1996-02-15 The Rockefeller University Modulation of thymocyte and t cell functional activity
EP0833656A4 (en) * 1995-06-09 1999-02-03 Yeda Res & Dev RESTRICTINE P / ACTIVINE A CONTAINING PHARMACEUTICAL COMPOSITIONS AND THEIR USE AS IL-6 OR / AND IL-11 ANTAGONISTS
US5736537A (en) * 1995-09-12 1998-04-07 Estee Lauder, Inc. Dehydroep:androsterone sailcylate useful against skin atrophy
DE19536223A1 (de) * 1995-09-28 1997-04-03 Dystar Textilfarben Gmbh & Co Verfahren zum Färben von synthetischen Polyamidfasermaterialien
AU2002210952B2 (en) 2000-10-25 2007-01-11 Chugai Seiyaku Kabushiki Kaisha Preventives or remedies for psoriasis containing as the active ingredient IL-6 antagonist

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4628052A (en) * 1985-05-28 1986-12-09 Peat Raymond F Pharmaceutical compositions containing dehydroepiandrosterone and other anesthetic steroids in the treatment of arthritis and other joint disabilities
NL194728C (nl) * 1987-04-16 2003-01-07 Hollis Eden Pharmaceuticals Farmaceutisch preparaat geschikt voor de profylaxe of therapie van een retrovirale infectie of een complicatie of gevolg daarvan.
US5077284A (en) * 1988-12-30 1991-12-31 Loria Roger M Use of dehydroepiandrosterone to improve immune response

Also Published As

Publication number Publication date
WO1993021771A1 (en) 1993-11-11
CA2134228A1 (en) 1993-11-11
EP0637915A4 (en) 1998-09-02
EP0637915A1 (en) 1995-02-15
NZ252491A (en) 1997-05-26
AU4225193A (en) 1993-11-29
JPH07506372A (ja) 1995-07-13
FI944984A0 (fi) 1994-10-24
AU675222B2 (en) 1997-01-30

Similar Documents

Publication Publication Date Title
FI980630A (fi) Menetelmä klavulaanihapon valmistamiseksi
FI951439A0 (fi) Mikro-organismit tryptofaanin tuottamista varten ja näiden valmistusmenetelmät
FI945441A (fi) Uusi menetelmä 7beta-substituoitu-4-atsa-5alfa-androstan-3-onien valmistamiseksi
HU9402817D0 (en) Compounds for treating allergic and inflammatory diseases
DE69322807D1 (de) Zahnprothese und Herstellungsverfahren
EP0634930A4 (en) Compounds useful for treating allergic and inflammatory diseases.
HU9500122D0 (en) Method for improved manufacture of cement in long kilns
FI940509A0 (fi) Menetelmä normaalin ja ultrahienon sementin valmistamiseksi
NO963785D0 (no) Fremgangsmåte for behandling av 5HT2B-reseptor-relaterte betingelser
NO307967B1 (no) FremgangsmÕte og mellomprodukter for fremstilling av benzopyranforbindelser
HUT58877A (en) Ball-duct and method for producing the ball-deflecting structures of this ball-duct
FI91240B (fi) Menetelmä hapen ja/tai otsonin valmistamiseksi
FI963050A0 (fi) Menetelmä klavulaanihapposuolan valmistamiseksi
PL289001A1 (en) Method and device for the production of multi-layered slabs
FI944984A0 (fi) Yhdisteet ja menetelmä IL-6 in vivo tapahtuvan valmistuksen säätämiseksi
KR900009566A (ko) 말레이미드류의 제조법
DE59305647D1 (de) Verfahren zur herstellung von alkylglykosiden und ihre verwendung
NO940171L (no) Fremgangsmåte for kontinuerlig fremstilling av dimetoksyetanal
HUT50249A (en) Method and apparatus for controlling the state of long structures
HU9202064D0 (en) Heterocyclic compounds of renine-inhibiting effect and method for production and application of these compounds
NO942531D0 (no) Fremgangsmåte for fremstilling av 3-acylöstratriener og acylbenzener
HU9201342D0 (en) Process for the production of n-hydroxi-n-/3-/2-substituted phenyl/-prop-2-enyl/-carbamides and tiocarbamides
NO943548D0 (no) Fremgangsmåte og mellomprodukter for fremstilling av 2-substituerte benzaldehyder
FI945119A (fi) Menetelmä 3(S)-metyyliheptaanihapon valmistamiseksi ja välituotteet
NO933076L (no) Næringssammensetning og fremgangsmåte for fremstilling

Legal Events

Date Code Title Description
FD Application lapsed